Genentech to start new trial for Alzheimer’s drug
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Genentech, an American subsidiary of the Basel-based pharmaceutical company Roche, will start a second Phase 3 clinical trial for its Alzheimer’s therapy crenezumab.
clement01.03.2017







